Further studies have confirmed the overexpression of LGI2 in patients with lung squamous cell carcinoma (Zeng et al., 2024) and in non-melanoma skin cancer model mice (Sarwar et al., 2023). This evidence concerns the gene LGI2 and non-melanoma skin carcinoma.